Israel Englander 9 Meters Biopharma, Inc. Transaction History

Millennium Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.21 - $0.32 $187,308 - $285,422	-891,945 Reduced 48.19%	958,880 $206,000
Q2 2022 Aug 15, 2022	BUY	$0.26 - $0.64 $481,214 - $1.18 Million	1,850,825 New	1,850,825 $483,000
Q1 2022 May 16, 2022	SELL	$0.52 - $1.0 $17,790 - $34,212	-34,212 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.33 $491,151 - $768,507	-577,825 Reduced 94.41%	34,212 $33,000
Q3 2021 Nov 15, 2021	SELL	$1.03 - $1.41 $2.26 Million - $3.09 Million	-2,194,829 Reduced 78.2%	612,037 $796,000
Q2 2021 Aug 16, 2021	BUY	$1.04 - $1.5 $972,470 - $1.4 Million	935,068 Added 49.96%	2,806,866 $3.09 Million
Q1 2021 May 17, 2021	BUY	$0.84 - $2.16 $1.43 Million - $3.67 Million	1,699,672 Added 987.46%	1,871,798 $2.19 Million
Q4 2020 Feb 16, 2021	SELL	$0.65 - $1.11 $486,994 - $831,636	-749,222 Reduced 81.32%	172,126 $148,000
Q3 2020 Nov 16, 2020	BUY	$0.48 - $0.84 $442,247 - $773,932	921,348 New	921,348 $751,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.